World Journal of Cardiovascular Diseases

Vol.11 No.1(2021), Paper ID 106666, 11 pages

DOI:10.4236/wjcd.2021.111005

 

Effects of Palivizumab Guideline Changes on RSV Admissions in Patients with Congenital Heart Disease and Prematurity

 

John Pham, Stephen Nageotte, Jon Detterich, Grace Kung

 

Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, United States of America
Division of Cardiology, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, United States of America
Division of Cardiology, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, United States of America
Division of Cardiology, Department of Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA, United States of America

 

Copyright © 2021 John Pham, Stephen Nageotte, Jon Detterich, Grace Kung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Pham, J. , Nageotte, S. , Detterich, J. and Kung, G. (2021) Effects of Palivizumab Guideline Changes on RSV Admissions in Patients with Congenital Heart Disease and Prematurity. World Journal of Cardiovascular Diseases, 11, 34-44. doi: 10.4236/wjcd.2021.111005.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.